Posted by Michael Wonder on 28 Oct 2020
UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine
28 October 2020 - The UK’s MHRA has begun the rolling review process of Moderna’s COVID-19 vaccine candidate, mRNA-1273.
This means that Moderna has started the rolling submission of mRNA-1273 for rolling review, in consideration of a potential authorisation by the MHRA.
